Market Research Future (MRFR) has released a new research report on the global apoptosis assays market. The report projects the global apoptosis assays market to exhibit a CAGR of 9.4% over the forecast period from 2018 to 2023. The global apoptosis assays market was valued at USD 2.99 billion in 2017. The report also contains detailed profiles of the market’s leading players, major regional segments, and key drivers and restraints expected to affect the market’s growth over the forecast period.

Apoptosis is the natural, pre-programmed cell death occurring to accommodate the growth of the organism. Studying apoptosis processes has become a crucial avenue for healthcare researchers in the last few years due to its importance in cancer research and studies of cell behavior. Growing cell-based research to understand the intricacies of cell behavior is likely to be a major driver for the global apoptosis assays market share over the forecast period.

Cell-based research is likely to remain a promising and lucrative avenue for medical researchers in the coming years due to the application of cellular therapies in a number of diseases. The growing government support to cellular research in the form of funding is also likely to remain a major driver for the global apoptosis assays market over the forecast period.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6799

The growing demand and financial support for cancer research is also likely to play a key role in the growth of the global apoptosis assays market over the forecast period. Cancer research includes aspects of cellular morphology and cell behavior, leading to apoptosis assays becoming an important avenue for cancer researchers.

Stem cell research is also a vital application for the apoptosis assays market and is likely to be a major part of the market over the forecast period. Stem cell research has taken prominence in the healthcare sector in recent years due to its utility in treating a number of life-threatening conditions and is likely to receive steady private funding as well as increasing government support over the forecast period, leading to steady growth of the apoptosis assays market.

On the other hand, the high costs of apoptosis assays are likely to be a major restraint against the global apoptosis assays market over the forecast period.

Competitive Analysis:

Leading players in the global apoptosis assays market include Merck KGaA, Bio-Rad Laboratories, Danaher Corporation, Sartorius AG, GeneCopoeia Inc., Promega Corporation, Geno Technology, Becton, Dickinson and Company, GE Healthcare, Thermo Fisher Scientific, and Abcom PLC.

Segmentation:

The global apoptosis assays market has been segmented on the basis of product, detection technology, application, end user, and region.

Based on product, the global apoptosis assays market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share segment of the market in 2017 and is likely to remain the dominant contributor to the market over the forecast period.
Based on detection technology, the apoptosis assays market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others.
Based on application, the global apoptosis assays market is segmented into drug discovery and development, stem cell research, and others.
Based on end user, the apoptosis assays market is segmented into pharmaceutical and biological companies, research institutes, and others.
Regional Analysis:

The global apoptosis assays market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/apoptosis-assays-market-6799

The Americas, led by North America, is likely to be the major regional segment of the global apoptosis assays market over the forecast period. The healthy medical research sector in North America is likely to be a key driver for the global apoptosis assays market over the forecast period, as is the strong stem cell research and cancer research scenarios in the region.

Europe is also likely to hold a dominant share in the global apoptosis assays market, following North America, due to the presence of a well-stocked, well-funded medical research sector.

Industry Updates:

In September 2018, apoptosis assays were used in a study related to reversing platinum resistance in ovarian cancer multicellular spheroids. Cancer research is likely to remain a promising avenue for apoptosis assays market players over the forecast period.